Rationale: Peroxisome proliferator-activated receptors (PPARs) (␣, ␥, and ␦/␤) are nuclear hormone receptors and ligand-activated transcription factors that serve as key determinants of myocardial fatty acid metabolism. Long-term cardiomyocyte-restricted PPAR␦ deficiency in mice leads to depressed myocardial fatty acid oxidation, bioenergetics, and premature death with lipotoxic cardiomyopathy. Objective: To explore the essential role of PPAR␦ in the adult heart. Methods and Results: We investigated the consequences of inducible short-term PPAR␦ knockout in the adult mouse heart. In addition to a substantial transcriptional downregulation of lipid metabolic proteins, short-term PPAR␦ knockout in the adult mouse heart attenuated cardiac expression of both Cu/Zn superoxide dismutase and manganese superoxide dismutase, leading to increased oxidative damage to the heart. Moreover, expression of key mitochondrial biogenesis determinants such as PPAR␥ coactivator-1 were substantially decreased in the short-term PPAR␦ deficient heart, concomitant with a decreased mitochondrial DNA copy number. Rates of palmitate and glucose oxidation were markedly depressed in cardiomyocytes of PPAR␦ knockout hearts. Consequently, PPAR␦ deficiency in the adult heart led to depressed cardiac performance and cardiac hypertrophy. Conclusions: PPAR␦ is an essential regulator of cardiac mitochondrial protection and biogenesis and PPAR␦ activation can be a potential therapeutic target for cardiac disorders. (Circ Res. 2010;106:911-919.)
P eroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors with well documented roles in the transcriptional regulation of lipid and carbohydrate metabolisms in various tissues. In the heart, the 3 subtypes of PPARs, PPAR␣, -␥, and -␦, are expressed at various levels and play important roles in myocardial lipid and glucose metabolisms. [1] [2] [3] [4] [5] [6] [7] We have demonstrated that PPAR␦ is required for normal transcript expression of series essential enzymes of fatty acid oxidation (FAO) in the heart and that cardiomyocyte-restricted PPAR␦ knockout results in depressed myocardial FAO and bioenergetics, cardiac hypertrophy and heart failure. 8, 9 Furthermore, there is emerging evidence demonstrating that PPARs may play a role in regulating transcriptional expression of antioxidants, such as Cu/Zn superoxide dismutase (SOD1), 10 manganese superoxide dismutase (SOD2), 11, 12 and catalase. [13] [14] [15] In a recent study, we demonstrated that PPAR␥ is essential for the full expression of SOD2 transcript in the heart. 14 Recent evidence has been emerging that PPAR␦ may contribute to transcrip-tional regulation of mitochondrial biogenesis in skeletal muscle. 16, 17 However, it remains unknown whether PPAR␦ regulates transcriptional expression of important antioxidants and key determinants of mitochondrial biogenesis to maintain cardiac mitochondrial biogenesis and function.
Mitochondria are the powerhouses for the cell and are vulnerable targets of oxidative damage. The maintenance of redox homeostasis is critical for normal cellular function and is particularly important for the heart with high energy demand. Impaired mitochondria structure/function as a result of increased oxidative stress is an important contributor to the pathogenesis of heart disease. Even under normal physiological conditions, the utilization of oxygen for energy generation in the mitochondria results in the production of reactive oxygen species (ROS). Typically, redox homeostasis is maintained by a balance between ROS formation and endogenous antioxidant defenses. It has been well established that multiple endogenous antioxidants such as SOD1, 10 SOD2, 11, 12 and catalase 18, 19 are all crucial in maintaining cellular redox balance. However, if this balance is disturbed, oxidative stress increases, leading to damage of essential cellular components, including the mitochondria. On the other hand, mitochondrial biogenesis is a continuous renewal process marked by regular mitochondrial turnover with a defined half-life. The molecular mechanisms underlying its regulation, especially its response to pathophysiological stimuli, including oxidative stress, remain puzzling. The roles of PPAR coactivator (PGC)1 (PGC-1␣ and -␤), 20 -24 nuclear regulatory factor (NRF)1, and NRF2s (NRF2␣ and -␤) 24, 25 in mitochondrial biogenesis have been documented. It is also well documented that PGC-1␣ is an important coactivator for a series of nuclear receptors, including PPAR␦ and estrogen-related receptor-␣. 26, 27 PPAR␦ can directly regulate the expression of PGC-1␣ and may contribute to transcriptional regulation of mitochondrial biogenesis in skeletal muscle. 17, 26 However, it remains unclear whether PPAR␦ is essential in the transcriptional regulation of mitochondrial biogenesis in the heart.
In the present study, we used an inducible gene targeting approach that enables short-term inactivation of PPAR␦ in the adult heart. We used this approach to examine the role of PPAR␦ in the adult heart not only in the transcriptional regulation of myocardial FAO but also its potential role in regulating endogenous antioxidants as well as mitochondrial biogenesis. We demonstrate for the first time that PPAR␦ not only regulates the expression of both SOD1 and SOD2, but also is an essential determinant of mitochondrial biogenesis in the heart. These findings will help provide insights into the role of PPAR␦ in governing metabolic homeostasis of the heart and in the development of novel therapeutic target for cardiac disorders.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Tamoxifen-Inducible Cardiomyocyte-Restricted PPAR␦ Knockout Line
Homozygous TMPD (tamoxifen-inducible cardiomyocyte-restricted PPAR␦ knockout) mice (C57/B6) were generated by crossing a transgenic line with ␣-myosin heavy chain (␣-MyHC)-driven Mer-Cre-Mer (MCM) overexpression 28 and the PPAR␦ flox/flox line. 29 Cardiomyocyterestricted PPAR␦ knockout was induced in 2-to 3-month-old mice by 5 days of tamoxifen treatment (2 mg/200 L in sunflower oil, IP injection). All experimental procedures were conducted in accordance with the NIH Guide for Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham.
Glucose Uptake, Glucose Oxidation, and Palmitate Oxidation Rates in Cultured Adult Mouse Cardiomyocytes
Adult cardiomyocytes were isolated from 9-to Ϸ13-week-old mice according to a published protocol. 30 Glucose uptake and glucose and palmitate oxidation rates were measured as described in the Online Data Supplement.
Transcript Analysis
Total RNA samples were extracted from left ventricles and analyzed by quantitative real-time RT-PCR (QPCR) as described in the Online Data Supplement.
Protein Analysis
Protein samples were prepared and analyzed using Western blots as described in the Online Data Supplement.
Analysis of Mitochondrial DNA Copies
Mitochondrial DNA copy number was evaluated as described in the Online Data Supplement.
Myocardial Lipid Profile
Quantification of TG content and individual species was measured by the Analytic Resources Core of the National Mouse Metabolic Phenotyping Center at Vanderbilt University as described in the Online Data Supplement.
Echocardiographic Measurement
Echocardiographic measurement with a high-resolution echocardiograph system (Visualsonic VEVO 770 System) was used to detect cardiac structure alterations and cardiac function in vivo by using echocardiogram with a 35 MHz probe. Details are described in the Online Data Supplement.
Mitochondrial Oxidative Stress
Methods for analyses of oxidative stress of cardiac mitochondria are described in the Online Data Supplement.
Statistics Analysis
Data for 2-group comparison were analyzed using Student t test; otherwise, the data were analyzed by 1-factor or mixed, 2-factor ANOVA using GraphPad Prism software (GraphPad Software Inc). Values of quantitative results were expressed as meansϮSEM. Differences between groups and treatments were regarded as significant at the PϽ0.05 probability level (denoted as *PϽ0.05, **PϽ0.01, ***PϽ0.001 in the charts and tables, unless indicated).
Results

Induced Cardiomyocyte-Restricted PPAR␦ Inactivation in Adult Mice Downregulates Cardiac Expression of Lipid Metabolic Proteins
To investigate the potential roles of PPAR␦ in the adult heart, we studied a mouse line with tamoxifen-induced cardiomyo- cyte-restricted PPAR␦ knockout. QPCR revealed that PPAR␦ transcript was markedly decreased in TMPD compared with tamoxifen-inducible MerCreMer (TMCM) mouse hearts 5 days after the end of tamoxifen treatment ( Figure 1A ).
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Western blot analysis revealed that PPAR␦ protein contents in left ventricles from TMPD were Ϸ20% of those from TMCM hearts from the above treatment groups ( Figure 1B ). On the other hand, the expression of the other two PPARs was not altered in the TMPD heart (Online Figure I) . QPCR further revealed that transcript levels of fatty acid uptake and FAO genes, such as heart type fatty acid binding protein (FABP), fatty acid transport protein (FATP)-1, carnitine palmitoyltransferase (CPT)Ib, and palmitoyl acyl-CoA oxidase 1 were respectively decreased by Ϸ40, Ϸ39, Ϸ37, and Ϸ61% in TMPD mice compared with TMCM controls ( Figure 1C ). Correspondingly, protein contents of FABP, FATP-1, and CPTIb in TMPD hearts were also decreased relative to those in TMCM mice, ( Figure 1D ). Interestingly, transcript expression of Glut1, but not Glut4, was decreased in the TMPD heart ( Figure 1E ). In protein level, Glut1 expression was decreased, whereas Glut4 expression was upregulated ( Figure 1F ). These results confirmed that PPAR␦ plays essential role in transcriptional regulation of myocardial lipid and glucose metabolism.
Short-Term Induction of PPAR␦ Deficiency in Adult Hearts Leads to Downregulation of SOD1 and SOD2, Leading to Increased Oxidative Stress
We further investigated whether PPAR␦ regulates transcriptional expression of antioxidants. QPCR revealed that transcripts of SOD1 and SOD2 were substantially attenuated in TMPD relative to TMCM hearts ( Figure 2A ). Western blotting analysis showed that the protein levels of SOD1 and SOD2 in TMPD hearts were decreased by Ϸ43% and Ϸ15% of those of control hearts ( Figure 2B ). However, both transcript and protein levels of catalase were unaltered in the TMPD relative to TMCM hearts (Figure 2A and 2B). We further evaluated cardiac mitochondrial oxidative stress on freshly isolated mitochondria samples from cardiac ventricular tissue. Cytochrome c reduction assays revealed that superoxide production in the TMPD hearts was increased by Ϸ33% compared with those of controls ( Figure 3A) . As a result, the TMPD hearts exhibited substantially suppressed mitochondrial aconitase activities ( Figure 3B ). Moreover, mitochondrial membrane potential estimated by JC-1 
-diethylbenzimidazole] uptake on samples isolated from TMPD hearts was declined by Ϸ30% compared with those of TMCM hearts ( Figure 3C ). MTT assay revealed that the activity of mitochondrial dehydrogenases was Ϸ25% lower in mitochondria from TMPD group than those of control ( Figure 3D ). Taken together, these results indicate that short-term PPAR␦ deletion leads to augmentation of reactive oxidative stress, supporting an essential role of PPAR␦ in antioxidant defense of the heart.
Short-Term Induction of PPAR␦ Deficiency in Adult Hearts Leads to Depressed Expression of Transcriptional Regulators of Mitochondrial Biogenesis, Concomitant With Mitochondrial Depletion
We further investigated whether PPAR␦ is a key determinant of mitochondrial biogenesis. QPCR revealed that the expression of mitochondrial biogenesis determinants, such as PPAR␥ coactivator 1 (PGC-1␣ and -1␤), NRF1, and NRF2 (␣ and ␤ subunit), was substantially declined in TMPD compared to TMCM hearts ( Figure 4A ). Western blotting analysis on samples of nuclear proteins extracted from ventricular tissues also confirmed that protein levels of PGC-1␣, PGC-1␤, NRF1, NRF2␣, and NRF2␤ in TMPD hearts were markedly decreased compared with those of the TMCM (Figure 4B , respectively). Transmission electron microscopy (TEM) assessment of heart sections from TMPD mice revealed striking mitochondrial abnormalities ( Figure 5A) , with a 45% decrease of mitochondria volume ( Figure 5B ) and apparent increase of vacuolated mitochondria compared with those of controls ( Figure 5A ). TEM also showed the widening of the I-band in TMPD heart sections ( Figure 5A ). The mtDNA copy number was decreased by Ϸ1/3 at 14 days after tamoxifen treatment in the TMPD relative to TMCM hearts ( Figure 5C ). Transcript expression of mitochondrial proteins such as mitofusin (Mfn)1, Mfn2, cytochrome b5, cytochrome c oxidase subunit II, and cytochrome c oxidase subunit 7c was also decreased in TMPD hearts ( Figure 5D ). Western blot analysis revealed that cytochrome b5, Mfn2, and mitochondrial fission 1 were decreased, whereas mitochondrial fission 1 protein remain unchanged in the TMPD compared to TMCM hearts ( Figure  5E ). Therefore, these results point to a novel function of PPAR␦ in the heart as a key regulator of mitochondrial biogenesis, and may also be involved in the regulation of mitochondrial fission and fusion.
Short-Term PPAR␦ Deficiency in the Adult Heart Leads to Depressed Rates of Both Palmitate and Glucose Oxidation in Cardiomyocytes
To determine the consequence of the depressed lipid metabolic gene expression and mitochondrial depletion on energy metabolism, rates of palmitate and glucose oxidation were evaluated in cultured cardiomyocytes from the short-term PPAR␦-deficient hearts. 14 C-palmitate oxidation rate in cultured cardiomyocytes isolated from adult TMPD hearts (14 days after the end of tamoxifen treatment) was attenuated by Ϸ40% compared with those of TMCM hearts ( Figure 6A ). The rate of glucose oxidation was also repressed in TMPD cardiomyocytes compared with controls ( Figure 6B ), which were consistent with the glucose uptake activity ( Figure 6C ). Lipid profiles revealed that phospholipids, triglyceride and cholesterol in the ventricular tissues remained at similar levels ( Figure 6D ). However, the percentage of triglyceride with palmitic (16:00) was increased by Ϸ20%, whereas percentage of linoleic (18:02) was slightly declined ( Figure  6E ). The phospholipids profile displayed little change with only a modestly increased proportion of arachidonic (20:04) ( Figure 6E ). These results further confirm the essential role of PPAR␦ in mitochondrial substrate metabolism in the adult heart.
PPAR␦ Deficiency in Adult Heart Leads to Cardiac Dysfunction and Cardiac Hypertrophy
With defects of myocardial FAO and mitochondrial depletion, the TMPD mice with PPAR␦ deficiency in a short period (14 days after tamoxifen treatment) in their hearts exhibited cardiac hypertrophy and cardiac dysfunction and became more severe with longer duration (7 months after the end of tamoxifen treatment). Heart weight/body weight ratio was increased Ϸ14% in TMPD mice after 14 days of induced PPAR␦ knockout compared to TMCM mice ( Figure 7A) . The transcript expression level of a hypertrophic marker, ␤ myosin heavy-chain (MYH7B), was increased ( Figure 7B ). Histological images of hematoxylin/eosin staining heart sections demonstrated cardiomyocyte hypertrophy with slight disarray ( Figure 7C ). Echocardiographic assessment ( Figure  7D ) revealed that the prolonged PPAR␦ deficient hearts were enlarged, with dilated chambers and thickening septum and posterior wall of left ventricles (Online Table II ). Cardiac hypertrophy in the TMPD mice was further confirmed by the increased LV mass to body weight ratio compared with that of the TMCM mice (Online Table II ). As a result, ejection fraction was declined by Ϸ12% and percentage fractional shortening was declined by Ϸ16.5% in the TMPD hearts compared with TMCM hearts (Online Table II ). Mitral valve inflow velocity with relatively prolonged deceleration rate and time was also noted in TMPD compared with TMCM hearts (Online Table II ). Cardiac function were further impaired in TMPD relative to TMCM mice 7 months after the end of tamoxifen treatment (Online Table III ). Ejection fraction was declined by Ϸ22% and percentage fractional shortening was declined by Ϸ28.9% in the TMPD hearts compared with TMCM hearts (Online Table III ).
Discussion
The goal of this study was to examine the role of PPAR␦ in the adult heart using a temporal, tissue-specific PPAR␦ knockout approach in mice. Our findings indicate that shortterm PPAR␦ deficiency in the adult mouse heart suppresses cardiac expression of key lipid metabolic proteins, essential endogenous antioxidants and transcriptional regulators of mitochondrial biogenesis, resulting in diminished fatty acid and glucose metabolism, mitochondrial depletion and abnormalities, cardiac dysfunction and hypertrophy.
We previously demonstrated that PPAR␦ is required for normal transcript expression of series essential enzymes that govern myocardial FAO in the long-term cardiomyocyterestricted PPAR␦ knockout (CR-PPAR␦ Ϫ/Ϫ ) mouse model. 3 These mice exhibited depressed myocardial FAO and bioenergetics, eventually leading to dilated cardiomyopathy with myocardial lipid accumulation in adult and older mice. 3, 9 The gene knockout event in the CR-PPAR␦ Ϫ/Ϫ mice, mediated by ␣-MyHC-driven expression of Cre recombinase, is expressed in ventricles during early development and robustly from new born stage. The heart mainly uses glucose as substrate to generate ATP in a newborn animal and switches to use long-chain fatty acids after weaning, which is concomitant with transcriptional upregulation of FAO genes. 31 Consequently, the early deficiency of fatty acid metabolism attributable to PPAR␦ inactivation may impact the normal developmental transition on the switch of substrate utilization, causing confounding phenotypes. Subsequent compensatory adaptive responses could obscure some of the primary regulatory effects of PPAR␦ in the heart. The temporally controlled, cardiomyocyte-restricted PPAR␦ deletion has the advantage in uncovering PPAR␦'s function in an adult heart. More important regulation roles of PPAR␦ could therefore be detected. In the present model, we uncovered additional functions of PPAR␦, such as glucose metabolism, antioxidants, and mitochondrial biogenesis, in the adult heart.
Recently, Koitabashi et al have reported that tamoxifenmediated MerCreMer nuclear translocation can induce severe transient dilated cardiomyopathy and dramatic increase of mortality in mice with or without loxP transgene. 32 However, we did not observe similar phenotypic changes at various time points using this approach (Online Figure I) . Most importantly, our study used TMCM mice as control to account for confounding effects of tamoxifen-induced Cre expression in the heart. Although the CR-PPAR␦ Ϫ/Ϫ hearts manifested progressive cardiac hypertrophy and heart failure, it is noteworthy that the long-term effect of PPAR␦ deficiency initiated in an adult heart was relatively modest compared with those of CR-PPAR␦ Ϫ/Ϫ hearts at similar adult ages. We observed more severe cardiac hypertrophy and cardiac dysfunction in TMPD mice but with no substantial decline of survival 7 months after the end of tamoxifen treatment. The consequences of early cardiac PPAR␦ deficiency likely contribute to the severe phenotypic changes in the CR-PPAR␦ Ϫ/Ϫ mice. It appears that the adult heart might have greater compensatory capacity in response to disturbances in myocardial homeostasis. Noticeably, the declined expression of both antioxidants and key factors in mitochondrial biogenesis was reversed (data not shown), possibly by other transcriptional regulators. Additional stimulation can augment the compensatory effect. 33 Therefore, the present findings are only possible with the use of the temporal conditional gene targeting approach, defining an important role of PPAR␦ in the adult heart.
In the present study, we report for the first time that PPAR␦ is a key transcription regulator of antioxidant defense and mitochondrial biogenesis in the adult heart. Transcriptional regulation of antioxidants has been extensively investigated. Furthermore, SOD1 was reported to be activated partly through the PPAR response element in its promoter. 13 We have also demonstrated that SOD2 is a direct target gene of PPAR␥ with a functioning PPAR response element consensus sequence in SOD2 promoter. 14 Our present study indicates that both SOD1 and SOD2 may be constitutively regulated by PPAR␦. Despite the potential compensatory upregulation of these proteins in response to hypertrophic stimuli, 34, 35 the expression of these proteins is remarkably decreased in the PPAR␦ deficient heart. In addition, the increased superoxide leads to augmented oxidative stress with marked mitochondrial oxidative injuries. Therefore, these observations provide insights into the novel aspects that endogenous antioxidants are transcriptional regulating targets of PPARs.
Mitochondrial biogenesis, which is the growth and division of preexisting mitochondria, is essential for the cell to cope with changes in energy demand. 25 The link between mitochondrial biogenesis and cardiac pathologies such as the hypertrophied or failing heart has increased the interest of the scientific community in this process and its regulations. 36 Regulation of mitochondrial biogenesis and function has been extensively studied, in particular with regard to the role of the PGC-1 family of transcriptional coactivators. 20, 24 A potential role of PPAR␦ in determining mitochondrial biogenesis in skeletal muscle has been suggested. 16 However, it remains unclear whether PPAR␦ directly mediates the transcriptional regulation of mitochondrial biogenesis in the adult heart. 37, 38 We have recently demonstrated that PPAR␦ directly regulates the expression of Mfn 2, an important mitochondrial protein in mitochondrial fusion and hence biogenesis. 39 In the present study, we found that PPAR␦ deficiency led to a remarkable decreased transcript and protein expression of both PGC-1␣ and PGC-1␤, the well-documented transcriptional determinants of mitochondrial biogenesis. 20 It has been known that disruption of normal mitochondrial function is an important stimulus for mitochondrial biogenesis. 25 With increased oxidative stress attributable to the diminished expression of key antioxidants, the depressed mitochondrial biogenesis in the TMPD heart is not likely a secondary response. Furthermore, it has been shown that PPAR␦ regulates PGC-1␣ gene expression by binding to the PPAR response element consensus sequence in the PGC-1␣ promoter. 17, 26 Because PGC-1␣ could induce NRF1 and NRF2 expression, 40, 41 it is plausible that the reduced NRF1 and NRF2 expression is directly related to decreased expression of PGC-1␣ in the PPAR␦ deficient heart. Because PGC-1␣ functions as a coactivator that boosts PPAR␦ activation by direct protein-protein interaction, 42, 43 stimulation of mitochondrial biogenesis by PGC-1␣ could, at least in part, be PPAR␦-mediated and could be relevant for the downstream metabolic responses. Therefore, it appears that PPAR␦ directed key mitochondrial protein expression may represent part of the role of PPAR␦ in governing mitochondrial biogenesis. The downregulation of Glut1 expression could be the results of depressed PGC-1␣. 37 In addition, the mitochondrial deficiency attributable to the depressed mitochondrial biogenesis and function should further contribute to the decrease of both palmitate and glucose oxidation in the TMPD heart.
With the obvious advantage of the tamoxifen inducible, cardiomyocyte-restricted gene knockout approach, we have found for the first time that PPAR␦ plays a crucial role not only in regulating myocardial lipid and glucose metabolism, but also in maintaining mitochondrial biogenesis and function via controlling expression of important endogenous antioxidants and key transcription regulators of mitochondrial protein expression. Therefore, we conclude that PPAR␦ not only regulates mitochondrial gene subgroup with roles in FAO, but also controls other gene subgroups with roles in mitochondrial biogenesis and function.
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